People · Operator
Named in public records as an officer, director or promoter · active 2009–2025 · Biotechnology, Other Health Care, Other Energy, Other, Other Technology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Neuros Medical, Inc. | — | Biotechnology | Series C | $160.0M | $338.5M | 2025 |
| Endotronix Inc | — | Other Health Care | Series C | $116.1M | $1.6B | 2018 |
| Cobalt Technologies Inc | — | Other Energy | Series B | $68.0M | $10.4M | 2011 |
| Rotation Medical Inc | — | Other Health Care | Series B | $51.1M | $177.2M | 2014 |
| Nkarta, Inc. | — | Biotechnology | Series C | $43.9M | $1.8B | 2019 |
| IlluminOss Medical Inc | — | Other | Series B | $39.9M | $83.0M | 2014 |
| Harvest Automation Inc | — | Other Technology | Series A | $31.5M | $79.7M | 2009 |
| Seahorse Bioscience Inc | — | Biotechnology | Series A | $20.7M | $410.2M | 2012 |
Fouad Azzam at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Fouad Azzam on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Ali Behbahani | 2 | 17 |
| Casey Tansey | 1 | 14 |
| David Stone | 1 | 12 |
| PAUL LAVIOLETTE | 1 | 12 |
| Eric Paley | 1 | 11 |
| John Nehra | 1 | 11 |
| Marc Goldberg | 1 | 9 |
| Russ Wilcox | 1 | 9 |
| Tiba Aynechi | 1 | 9 |
| Joyce Erony | 1 | 8 |
| Greg Young | 1 | 8 |
| John Hamer | 1 | 7 |
| Rajeev Dadoo | 1 | 7 |
| Kevin Sidow | 1 | 7 |
| Steven Young | 1 | 6 |
| Harry Wilcox | 1 | 6 |
| Enrico Petrillo | 1 | 6 |
| Marc-Andre Marcotte | 1 | 6 |
| Anthony J. Natale | 1 | 5 |
| Lee Wrubel | 1 | 5 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.